Menu
Recruiting NCT07662603

Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing

No phase Interventional Behcet Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: inspiratory muscle trianing.
Who it may be relevant to
Registry conditions: Behcet Disease. Basic parameters: 13 years — 17 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

physical complications are common in Behcet disease patients with pulmonary endoarterectomy, so outcomes of program of inspiratory msucle trianing must be investigated

Detailed description

Forty Behcet disease patients with pulmonary endoarterectomy will be assigned to group I or Group II. the patients will be adolescents, 20 patients in the group. Group I will recive program of inspiratory msucle trianing for 12 weeks (one session daily, except the last two days of the week) Group II will act waitlist group.

Interventions

  • Other inspiratory muscle trianing
    twenty Behcet disease patients with pulmonary endoarterectomy will be will recive program of inspiratory msucle trianing for 12 weeks (one session daily, except the last two days of the week)

Primary outcome measures

  • forced vital capacity [Time frame: it will be measured after 12 weeks]
Secondary outcome measures (9)
  • forced expiratory volume [Time frame: It will be measured after 12 weeks]
  • ratio of force vital capcity to first-second-expiratory forced expiration volume [Time frame: It will be measured after 12 weeks]
  • fatigue severity scale [Time frame: It will be measured after 12 weeks]
  • child health questainanire parent form assessment of phsyical summary [Time frame: it will be measured after 12 weeks]
  • child health questainanire parent form assessment of mental summary [Time frame: It will be measured after 12 weeks]
  • Ruffier index [Time frame: It will be measured after 12 weeks]
  • maxinmal inspiration pressure [Time frame: It will be measured after 12 weeks]
  • maxinmal expiration pressure [Time frame: It will be measured after 12 weeks]
  • six minute walk test [Time frame: It will be measured after 12 weeks]

Eligibility criteria

Inclusion criteria

  • adlescent patients
  • complain Behcet disease
  • after pulmonary endoarterectomy

Exclusion criteria

  • chronci cardiac diseases
  • psychic disease
  • mental disease

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Cairo University — Giza

Identifiers

NCT: NCT07662603 · IRB000-14233-81

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗